Congrats to our PhD student @sanukitissera and the team on their latest publication, emphasizing the critical role of guideline-concordant treatment in improving survival for patients with non-small cell lung cancer. Check out the full article: https://t.co/TzvtiqwXbd
Lung cancer survival rates in Victoria have increased over the last 5 years. The latest VLCR Annual Report shows a 5-year survival rate of 32.5% for NSCLC and 13.6% for SCLC. #LungCancer#SurvivalRates#Healthcare#VLCR#CancerResearch
Stepped palliative care may be an effective strategy for maintaining QoL in advanced #lungcancer#nsclc Reshaping the care package for patients with advanced disease
No one wants to work on a long weekend but each time I do I realise what a privilege it is to support our patients and to work with the very talented nurses, ward staff, allied health, admin, residents and registrars in our teams #AlfredHealth#RespiratoryMedicine#AlfredECMO
Why are our lung cancer patients not presented to multi disciplinary meetings? There is now good evidence to support significant treatment and survival benefits. https://t.co/m1UVXbd13H @lungcancer@NSCLC_cancer@VLCR_AU @unwarrantedvariation @disparity@equity@Monash_SPHPM
Multidisciplinary meeting presentation is a low-cost intervention providing substantial
benefits in receipt of treatment and survival. Up to 40% of patients remain unpresented,
risking disparity and inequity in treatment and outcomes. https://t.co/m1UVXbd13H @VLCR_AU#lungcancer
Did you know, before 2003, the IASLC endorsed several meetings on Targeted Therapy of Lung Cancer, & then took over the conference management/program. Ever since, the IASLC #TTLC meeting has been held in California, during the month of February, on an annual basis! #IASLC50#LCSM
Did you know, video-assisted thoracic surgery (VATS) is a type of minimally invasive surgery (introduced in the early 90's) for diagnosing/treating many thoracic conditions, including #lungcancer. It’s performed using a tiny tube w/a small video camera at the end. #LCSM#IASLC50
What do Lung Cancer patients think of existing Patient Reported Outcome Measures and think how they could be improved? How can we better engage lung cancer patients to develop more meaningful PROMs? See what we discovered. https://t.co/ckuoovd98A @VLCR_AU#lungcancer#PROMs
Non invasive treatment in autoimmune PAP is a highly effective treatment option in addition to WLL. see Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis https://t.co/IqVu5UNLMV